Project Grant R01HD112076

Award Date 1/13/25
Completion Date 12/31/29
Dollars Obligated $679K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $501,003 to the University of Utah to conduct research on optimal dosing of common asthma medications for pregnant individuals. The primary objectives are to: 1) develop physiologically-based pharmacokinetic (PBPK) models for two asthma drugs to understand how pregnancy affects their...
This federal Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 Child Health and Human Development Extramural Research) totaling $349,375 provides funding to The Trustees of the University of Pennsylvania to develop a targeted lipid nanoparticle platform for delivering therapeutic mRNA to the placenta to treat pre-eclampsia, a leading cause of maternal mortality worldwide. The primary goals are to: 1) utilize high-throughput screening to identify...
This Project Grant award of $234,000 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research to investigate immunometabolic dysregulations in offspring of obese mothers. The project aims to conduct a pre-clinical trial on using low-dose aspirin in pregnant mice to reduce the risk of obesity and metabolic diseases in their offspring. It will also determine whether metabolic...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $419,615 to support a 2-year postdoctoral training program in clinical pharmacology at Thomas Jefferson University and Children's Hospital of Philadelphia. The program aims to train the next generation of drug development scientists to advance innovation in therapeutics across pediatric,...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will provide $1,332,733 to The Trustees of the University of Pennsylvania to conduct research on the impact of preconception lifestyle factors on pregnancy outcomes. The research aims to leverage the linkage between the National Health and Nutrition Examination Survey (NHANES) and Medicaid data to...
This $828,321 federal Cooperative Agreement award from the National Institute of Child Health and Human Development (NICHD) under CFDA Program 93.865 "Child Health and Human Development Extramural Research" will fund a prospective, randomized controlled trial to evaluate the impact of treating asymptomatic bacteriuria (AB) in pregnancy on reducing the incidence of low birth weight in low- and middle-income countries. The project will be led by researchers from the Research Triangle...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $485,925 to the University of Massachusetts Boston to develop novel antioxidant compounds for treating preeclampsia, a life-threatening pregnancy complication. The primary goal is to design and synthesize cationic hydrazone antioxidants that can target mitochondria to reduce oxidative stress, improve...
This Project Grant award for $262,808 from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) supports research conducted by Beth Israel Deaconess Medical Center, Inc. (Bidmc) to develop and evaluate water-soluble prodrugs of the compound AKT-1005 as a potential treatment for preeclampsia. The key objectives are to synthesize, screen, and test the prodrugs for improved solubility, stability, and release of...
This $108,512 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support research at the University of Chicago to investigate the effects of maternal medication exposures on child health outcomes. The key objectives are to: 1) Build a high-quality registry of mother-child pairs containing structured and unstructured electronic medical record data, leveraging...
This federal Project Grant award, funded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports a research project entitled "Optimizing Decision-Making to Improve Maternal Outcomes in High-Risk Pregnant Patients with Hypertensive Disorders." The $170,420 award to New York University School of Medicine, starting on September 3, 2024, aims to characterize the risks of...

This federal Project Grant award of $678,809 from the National Institute of Child Health and Human Development (NICHD) under CFDA Program 93.865, Child Health and Human Development Extramural Research, supports a randomized controlled trial to investigate aspirin pharmacokinetics and pharmacodynamics in high-risk singleton pregnancies.

The objectives are to: 1) Determine platelet inhibition and factors impacting aspirin response at increased dosing through pregnancy; 2) Establish aspirin population pharmacokinetics and pharmacokinetic/pharmacodynamic relationships over gestation; and 3) Assess the association between aspirin response and perinatal outcomes. The research will be conducted by Thomas Jefferson University, doing business as Sidney Kimmel Medical College, a leading academic medical center, over the award period from January 13, 2025 to December 31, 2029.

Generated 6/24/25, 3:39 AM